Pesticide Residues in EU Herbal Supplements: Why EC 396/2005 Compliance Doesn't Protect You at the US or Canadian Border

A Certificate of Analysis confirming EC 396/2005 compliance doesn’t travel well across the Atlantic. We’ve seen this scenario unfold more times than we’d like: a well-established European herbal brand, clean EU paperwork in hand, receives an FDA refusal-of-admission notice on a botanical shipment — not because the product was dangerous, but because their pesticide testing protocol was designed entirely around EU market requirements. Two different regulatory systems, two different testing panels, and one expensive lesson in the limits of geography-specific compliance.

If you’re formulating or manufacturing herbal supplements in Europe with any intention of selling in the US or Canada, this disconnect matters far more than most EU-based quality teams appreciate.

What EC No 396/2005 Actually Covers

EC No 396/2005 is the EU’s core pesticide MRL framework, establishing maximum residue limits for pesticide residues in food and feed — including botanicals and food supplements. It’s comprehensive by European standards, covering hundreds of active substances and setting a uniform default MRL of 0.01 mg/kg (10 µg/kg) for any pesticide not explicitly listed in the regulation’s annexes.

That default 0.01 mg/kg limit is strict. And for the EU market, testing to this regulation alongside the European Pharmacopoeia’s Ph.Eur. 2.8.13 — which covers pesticide residues specifically in herbal drugs and sets individual limits for substances including aldrin, dieldrin, DDT, and several organophosphate classes — gives you a defensible compliance position with EU regulators and DGCCRF inspectors.

But here’s what the regulation doesn’t do: it doesn’t align with the pesticide tolerance system used by the US Environmental Protection Agency under 40 CFR Part 180, or the import standards enforced by the FDA under Section 801 of the FD&C Act. And the differences are more than administrative — they’re structural.

The FDA Pesticide Framework Operates on Different Logic

In the United States, pesticide tolerances for food and botanical products are established by the EPA under the Federal Food, Drug, and Cosmetic Act. The FDA enforces these tolerances at import. When a shipment of herbal supplement product arrives at a US port of entry, FDA officials can detain it under 21 U.S.C. § 381 if pesticide residues exceed EPA-established tolerances — or if residues are detected for pesticides with no established US tolerance at all.

That last point is where European brands consistently underestimate the risk. Under US law, any pesticide residue for which no tolerance has been established is treated as if the tolerance is zero. This is categorically different from the EU approach, where the 0.01 mg/kg default gives you a practical floor across all unlisted substances.

A pesticide commonly used in herb cultivation in China, Turkey, or India may be a known quantity in EU testing panels — tested, reported, and found comfortably below EC 396/2005 limits. But if that same compound has no established EPA tolerance, its presence in even trace amounts can trigger US import refusal. No EU compliance certificate changes this.

The FDA’s approach to dietary supplement inspections under 21 CFR Part 111 — Current Good Manufacturing Practice for dietary supplements — also requires that manufacturers test for purity, composition, and contamination. Pesticide residue testing is expected as a component of identity and purity testing for botanical raw materials. The question inspectors ask isn’t just whether you tested, but which panel and which limits your testing laboratory was working against.

USP <561> and What US Importers Actually Need from Your COA

The United States Pharmacopeia’s General Chapter <561>, “Articles of Botanical Origin,” provides the technical reference framework that US supplement manufacturers and their QA teams actually use when specifying what botanical ingredient testing looks like. It addresses identity, purity, and quality for botanical materials, and includes pesticide residue considerations aligned with broader USP/NF requirements.

When a US importer or contract manufacturer asks for pesticide residue testing “per USP standards,” they’re expecting a panel that reflects US market realities: specific compounds documented in USP reference materials, limits aligned with EPA-established tolerances, and methodology validated against analytical guidance in USP <561> and related general information chapters. A comprehensive screening panel for US-market botanical ingredients routinely covers 200 or more individual compounds, using validated GC-MS/MS and LC-MS/MS methods calibrated to US tolerance thresholds — not EU MRL limits.

Here’s the practical gap: most European testing laboratories build their pesticide screening panels around European Pharmacopoeia methods and EC 396/2005 MRL tables. This makes complete sense for EU market compliance. But the two panels don’t fully overlap. Compounds prioritized for European agricultural use patterns may not include certain organochlorine or organophosphate residues specifically associated with botanical supply origins in Asia — origins that represent a significant proportion of the global herbal ingredient trade.

The practical implication is something EU quality teams find uncomfortable: your EU COA may report a clean “pass” against EC 396/2005, while a US-compliant COA on the same batch could tell a different story. Not because the product changed — because the analytical question changed.

Health Canada’s PMRA MRLs: A Third Framework That Surprises Even Experienced EU Exporters

European brands that budget carefully for both EU and US compliance sometimes overlook a third framework entirely: Canada’s. Health Canada’s Pest Management Regulatory Agency establishes maximum residue limits for pest control products under the Pest Control Products Act. These MRLs are not simply adopted from either the EU or the US — they’re independently established and can differ materially from both.

For herbal supplements sold as Natural Health Products in Canada, compliance with the Natural Health Products Regulations (SOR/2003-196) requires, among other things, that finished products meet Canadian safety standards — including PMRA MRL limits for pesticide residues. The PMRA does harmonize some limits with Codex Alimentarius MRLs and, increasingly, with US EPA tolerances, but meaningful divergences remain, particularly for compounds used in botanical cultivation outside North America.

Where this creates practical complexity for EU brands: a product tested to EC 396/2005 compliance, then reformatted for US sale with EPA-aligned testing, may still require a third round of COA review against PMRA limits before a Canadian distributor will accept it for NPN-licensed product or before a Health Canada compliance review. We’ve seen EU brands with robust US market documentation encounter exactly this friction when they begin Canadian distribution — additional confirmatory testing is requested, and the brand’s COA architecture isn’t built to answer the question efficiently.

Building a Testing Protocol That Works Across All Three Markets

The good news is that a well-designed multi-market testing strategy can cover all three regulatory systems without tripling analytical costs. It requires planning at the raw material qualification stage — not at the finished-product release stage, which is where most EU brands try to retrofit compliance documentation.

A multi-market botanical pesticide testing protocol should address four things:

Compound selection. Build your screening panel around the union of EC 396/2005 annexes, EPA 40 CFR Part 180 tolerance tables, and PMRA MRL tables for your specific botanical ingredients. For supply origins in China, India, or Eastern Europe, add compounds known from supply chain incident data to carry elevated residue risk from local agricultural practices.

Method validation. Your laboratory’s analytical methods need to be validated to detection limits sufficient to satisfy all three systems. The EU default of 0.01 mg/kg is often your lowest common denominator on acceptable limits — but EU-validated methods aren’t always qualified to the detection levels US or Canadian review processes expect for specific compound classes.

COA architecture. A single COA report can be designed to serve multiple markets without re-testing. Consider generating jurisdiction-specific addendum reports that cross-reference the same underlying analytical data against EC 396/2005 limits, EPA 40 CFR 180 tolerances, and PMRA MRLs separately. This is operationally feasible and significantly more efficient than three separate analytical runs.

Supply chain traceability. Where possible, source botanicals from suppliers who provide their own pesticide residue data at the raw material level, referenced against their specific growing region and agricultural inputs. This gives your QA team early warning before finished-product testing reveals a compliance issue — at which point your options are limited and expensive.

For European brands operating without access to a laboratory experienced in both Ph.Eur. and USP/AOAC methods, this is where a partner-lab network with transatlantic reach matters most. The analytical work for EU compliance and the analytical work for FDA or Health Canada compliance are technically related but operationally distinct — distinct enough that your testing laboratory needs genuine familiarity with both frameworks to deliver results you can actually use across markets.

---

If your current pesticide testing protocol was built around EC 396/2005 and Ph.Eur. 2.8.13, it’s doing exactly what it was designed to do: serving the EU market. The moment your commercial strategy extends to the US or Canada, that protocol becomes a starting point — not a finish line. The most cost-effective way to close the gap is to build multi-market compliance logic into your raw material qualification programme, well before a product is formulated and certainly before it arrives at a North American port of entry.

---

Written by Nour Abochama, Quality & Regulatory Advisor, Care Europe | VP Operations, Qalitex. Learn more about our team

Talk to our team about EU market entry. Contact us

Related from our network

• ISO 17025-accredited botanical and supplement testing to USP and AOAC standards — Qalitex Laboratories provides pesticide residue screening panels validated for the US market, including COA formats accepted by FDA-compliant importers.
• Natural Health Product testing and compliance support for Canadian market entry — Androxa supports European brands with PMRA-referenced pesticide COA documentation as part of Health Canada NPN application preparation.